The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
Condition: Refractory/Relapsed Autoimmune Hemolytic Anemia Intervention: Drug: Zanubrutinib Sponsor: Institute of Hematology & Blood Diseases Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials